Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Colucid Pharma Cmn (CLCD)

Colucid Pharma Cmn (CLCD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 897,098
  • Shares Outstanding, K 19,280
  • Annual Sales, $ 0 K
  • Annual Income, $ -30,740 K
  • 60-Month Beta 1.51
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 9.55
Trade CLCD with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.70
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/01/17
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/16
See More
  • Average Estimate -0.88
  • Number of Estimates 2
  • High Estimate -0.85
  • Low Estimate -0.91
  • Prior Year -0.74
  • Growth Rate Est. (year over year) -18.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
46.20 +0.71%
on 01/30/17
46.65 -0.26%
on 02/08/17
+0.28 (+0.61%)
since 01/27/17
3-Month
31.25 +48.90%
on 01/06/17
46.65 -0.26%
on 02/08/17
+12.63 (+37.26%)
since 11/28/16
52-Week
5.26 +784.60%
on 05/09/16
46.65 -0.26%
on 02/08/17
+40.87 (+722.08%)
since 02/26/16

Business Summary

CoLucid Pharmaceuticals, Inc. is a biopharmaceutical company which develops molecule for the treatment of migraine headaches. The company's product candidate consists of oral Lasmiditan for the treatment of migraine headache and intravenous lasmiditan for treatment of headache pain, which are in different...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 46.61
1st Resistance Point 46.57
Last Price 46.53
1st Support Level 46.47
2nd Support Level 46.41
3rd Support Level N/A

See More

52-Week High 46.65
Last Price 46.53
Fibonacci 61.8% 30.84
Fibonacci 50% 25.96
Fibonacci 38.2% 21.07
52-Week Low 5.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar